Company profile: MBL International
1.1 - Company Overview
Company description
- Provider of life science research products, including MHC tetramers for analyzing antigen-specific T cell responses; IL-18 antibodies, ELISA kits, and recombinant proteins; a broad range of monoclonal and polyclonal antibodies; recombinant proteins such as Afamin/Wnt3a and R-spondin 1; ELISA and apoptosis assay kits; and Afamin/Wnt3a conditioned medium for organoid and stem cell culture.
Products and services
- Antibodies: MBL International supplies research-grade monoclonal and polyclonal antibodies that target various proteins and markers for research applications
- MHC Tetramers: Custom-engineered complexes used to analyze antigen-specific T-cell responses by binding T cells recognizing specific peptide sequences, providing detailed information on T-cell activity
- IL-18 Products: Modular research kits and reagents including IL-18 antibodies, ELISA kits, and recombinant proteins for studying IL-18’s role in immune responses and various diseases
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to MBL International
NanoSight
HQ: United Kingdom
Website
- Description: Provider of instruments for optical detection and real-time analysis of sub-micron particles, including NanoSight Pro, a machine learning nanoparticle analyzer enabling automated particle tracking and analysis of 10 to 1000 nm with fluorescence detection, and Smart Manager, a cloud-connected solution for continuous data analysis, improving data management and accessibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NanoSight company profile →
Avadel Pharmaceuticals
HQ: Ireland
Website
- Description: Provider of specialty pharmaceutical products developed via proprietary drug delivery technology and in-licensing/acquisitions to create safe, effective, easy-to-take formulations; offers LUMRYZ, a central nervous system depressant for treating cataplexy or excessive daytime sleepiness in adults with narcolepsy, available through a restricted program.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Avadel Pharmaceuticals company profile →
Zynerba Pharmaceuticals
HQ: United States
Website
- Description: Provider of innovative transdermal cannabinoid treatments for neuropsychiatric disorders, developing proprietary dermal solutions and therapeutic candidates using modern drug delivery technology. Offers Zygel (ZYN002 cannabidiol gel) for Fragile X syndrome and 22q11.2 deletion syndrome, and conducts clinical trials across various countries to assess its safety and efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zynerba Pharmaceuticals company profile →
Manhattan Scientifics
HQ: United States
Website
- Description: Provider of nanomedicine technology transfer and commercialization, including nanostructured metals that enhance strength and biocompatibility for medical devices; Magnetic Relaxometry cancer detection using superparamagnetic nanoparticles and sensitive magnetic detectors to identify and locate early-stage cancers; and MicroFuel Cell technology for 'always on' portable power in small electronics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Manhattan Scientifics company profile →
Dreamweaver
HQ: United States
Website
- Description: Provider of nonwoven battery separators made from a combination of nanofibers and microfibers, enabling 300% higher power through increased electricity transmission in batteries and improving power in electric vehicles, power tools, and other high-power applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dreamweaver company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for MBL International
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to MBL International
2.2 - Growth funds investing in similar companies to MBL International
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for MBL International
4.2 - Public trading comparable groups for MBL International
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →